CD14 and autoimmune thrombocytopenic purpura: Then the expression of GSK‐3β was further analyzed in monocytes, newly diagnosed ITP patients and non‐response patients obtained higher GSK‐3β+ cells in CD14+ monocytes, while ITP patients achieving PR and CR have reduced GSK‐3β+ monocytes (Figure 1D; Figure S3D, Supporting Information).